|
FSI
Flexible Solutions International Inc
FSI · Q3 FY2023
|
Q3 FY2023 |
|
FSI Q3 FY2023 transcript
|
|
PWCM
Powercompute, Inc.
PWCM · Q3 FY2023
|
Q3 FY2023 |
|
PWCM Q3 FY2023 transcript
|
|
RDI
Reading International Inc
RDI · Q3 FY2023
|
Q3 FY2023 |
|
RDI Q3 FY2023 transcript
|
|
RMR
Rmr Group Inc.
RMR · Q4 FY2023
|
Q4 FY2023 |
|
RMR Q4 FY2023 transcript
|
|
NUE
Nucor Corp
NUE · Q3 FY2023
|
Q3 FY2023 |
|
NUE Q3 FY2023 transcript
|
|
NVGS
Navigator Holdings Ltd.
NVGS · Q3 FY2023
|
Q3 FY2023 |
|
NVGS Q3 FY2023 transcript
|
|
DAC
Danaos Corp
DAC · Q3 FY2023
|
Q3 FY2023 |
|
DAC Q3 FY2023 transcript
|
|
SACH
Sachem Capital Corp.
SACH · Q3 FY2023
|
Q3 FY2023 |
|
SACH Q3 FY2023 transcript
|
|
ASPN
Aspen Aerogels Inc
ASPN · Q3 FY2023
|
Q3 FY2023 |
|
ASPN Q3 FY2023 transcript
|
|
HSAI
Hesai Group
HSAI · Q3 FY2023
|
Q3 FY2023 |
|
HSAI Q3 FY2023 transcript
|
|
TSHA
Taysha Gene Therapies, Inc.
TSHA · Q3 FY2023
|
Q3 FY2023 |
|
TSHA Q3 FY2023 transcript
|
|
ARMK
Aramark
ARMK · Q4 FY2023
|
Q4 FY2023 |
|
ARMK Q4 FY2023 transcript
|
|
SHFS
SHF Holdings, Inc.
SHFS · Q3 FY2023
|
Q3 FY2023 |
|
SHFS Q3 FY2023 transcript
|
|
LUCD
Lucid Diagnostics Inc.
LUCD · Q3 FY2023
|
Q3 FY2023 |
|
LUCD Q3 FY2023 transcript
|
|
INLX
Intellinetics, Inc.
INLX · Q3 FY2023
|
Q3 FY2023 |
|
INLX Q3 FY2023 transcript
|
|
NDRA
ENDRA Life Sciences Inc.
NDRA · Q3 FY2023
|
Q3 FY2023 |
|
NDRA Q3 FY2023 transcript
|
|
WKHS
Workhorse Group Inc.
WKHS · Q3 FY2023
|
Q3 FY2023 |
|
WKHS Q3 FY2023 transcript
|
|
URGN
UroGen Pharma Ltd.
URGN · Q3 FY2023
|
Q3 FY2023 |
|
URGN Q3 FY2023 transcript
|
|
AREC
American Resources Corp
AREC · Q3 FY2023
|
Q3 FY2023 |
|
AREC Q3 FY2023 transcript
|
|
NPWR
Net Power Inc.
NPWR · Q3 FY2023
|
Q3 FY2023 |
|
NPWR Q3 FY2023 transcript
|
|
CRMD
CorMedix Inc.
CRMD · Q3 FY2023
|
Q3 FY2023 |
|
CRMD Q3 FY2023 transcript
|
|
IPW
iPower Inc.
IPW · Q1 FY2024
|
Q1 FY2024 |
|
IPW Q1 FY2024 transcript
|
|
IPWR
Ideal Power Inc.
IPWR · Q3 FY2023
|
Q3 FY2023 |
|
IPWR Q3 FY2023 transcript
|
|
ITRMF
Iterum Therapeutics plc
ITRMF · Q3 FY2023
|
Q3 FY2023 |
|
ITRMF Q3 FY2023 transcript
|